Use of sodium zirconium cyclosilicate for up-titration of renin–angiotensin–aldosterone system inhibitor therapy in patients with heart failure: a case series

BACKGROUND: Patients often receive suboptimal dosing of renin–angiotensin–aldosterone system inhibitor (RAASi) therapy over concerns of hyperkalaemia. However, studies have shown associations between suboptimal dosing or interruptions to therapy and adverse clinical events. Therefore, effective trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Rhys, James, Alexander, Ashton, Moira, Vaughan, Sian, Wong, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364764/
https://www.ncbi.nlm.nih.gov/pubmed/34409249
http://dx.doi.org/10.1093/ehjcr/ytab281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364764/
https://www.ncbi.nlm.nih.gov/pubmed/34409249
http://dx.doi.org/10.1093/ehjcr/ytab281

Ejemplares similares